TARGETING GLIOBLASTOMA WITH A BRAIN PENETRANT DRUG THAT IMPAIRS BRAIN TUMOUR STEM CELLS

被引：0
|
作者：
Jahani-Asl, Arezu [1 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
STEM-12
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CHARACTERISATION OF INVASION OF HUMAN BRAIN TUMOUR INITIATING CELLS IN HUMAN GLIOBLASTOMA
    Leidgens, Verena
    Alieva, Maria
    Lu, Xin
    Patwary, Nina
    Kerkhoff, Eugen
    Proescholdt, Martin
    Vollmann-Zwerenz, Arabel
    Van Rheenen, Jacco
    Klein, Christoph
    Hau, Peter
    NEURO-ONCOLOGY, 2017, 19 : 22 - 23
  • [32] Targeting DNA-PKcs and telomerase in brain tumour cells
    Resham Lal Gurung
    Hui Kheng Lim
    Shriram Venkatesan
    Phoebe Su Wen Lee
    M Prakash Hande
    Molecular Cancer, 13
  • [33] GLIOBLASTOMA A FATAL TUMOUR WITH STEM CELLS
    Moura-Neto, V.
    GLIA, 2013, 61 : S215 - S215
  • [34] Unmasking the face behind recurrence: mechanisms underlying drug resistance of brain tumour stem cells
    Martin, V.
    Alonso, M. M.
    Xu, J.
    Liu, D.
    Colman, H.
    Yung, W. K. A.
    Fueyo, J.
    Gomez-Manzano, C.
    JOURNAL OF NEUROLOGY, 2008, 255 : 18 - 19
  • [35] Brain drug targeting: the future of brain drug.
    Jensen, AF
    ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (01) : 80 - 80
  • [36] Drug targeting to the brain
    Pardridge, William M.
    PHARMACEUTICAL RESEARCH, 2007, 24 (09) : 1733 - 1744
  • [37] Drug targeting to the brain
    de Boer, A. G.
    Gaillard, P. J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 : 323 - 355
  • [38] Drug targeting to the brain
    Jaap Rip
    Geert J Schenk
    Albertus G de Boer
    BMC Proceedings, 2 (Suppl 1)
  • [39] Drug Targeting to the Brain
    William M. Pardridge
    Pharmaceutical Research, 2007, 24 : 1733 - 1744
  • [40] Studies on the use of NE-4C embryonic neuroectodermal stem cells for targeting brain tumour
    Demeter, K
    Zádori, A
    Agoston, VA
    Madarász, E
    NEUROSCIENCE RESEARCH, 2005, 53 (03) : 331 - 342
12345